These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 15855731)

  • 1. [Brain aging and insulin signals].
    Takashima A
    Nihon Yakurigaku Zasshi; 2005 Mar; 125(3):137-40. PubMed ID: 15855731
    [No Abstract]   [Full Text] [Related]  

  • 2. [Morphology and neurotoxicity of newly identified spherical beta-amyloid aggregates, 'amylospheroid', aiming at elucidation of the neurodegenerative cascades in Alzheimer's disease].
    Hoshi M
    Seikagaku; 2004 Jul; 76(7):631-9. PubMed ID: 15346899
    [No Abstract]   [Full Text] [Related]  

  • 3. Alzheimer's disease: Mental plaque removal.
    De Strooper B; Woodgett J
    Nature; 2003 May; 423(6938):392-3. PubMed ID: 12761533
    [No Abstract]   [Full Text] [Related]  

  • 4. [Alzheimer's disease: cellular and molecular aspects].
    Octave JN; Pierrot N
    Bull Acad Natl Med; 2008 Feb; 192(2):323-31; discussion 331-2. PubMed ID: 18819686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of insulin signaling rescues BDNF transport defects independent of tau in amyloid-β oligomer-treated hippocampal neurons.
    Takach O; Gill TB; Silverman MA
    Neurobiol Aging; 2015 Mar; 36(3):1378-82. PubMed ID: 25543463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration.
    Ramesh Babu J; Lamar Seibenhener M; Peng J; Strom AL; Kemppainen R; Cox N; Zhu H; Wooten MC; Diaz-Meco MT; Moscat J; Wooten MW
    J Neurochem; 2008 Jul; 106(1):107-20. PubMed ID: 18346206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Regulation of phosphorylation of tau by insulin and Ca2+ signals].
    Yamamoto H
    Nihon Yakurigaku Zasshi; 2005 Mar; 125(3):129-35. PubMed ID: 15855730
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduced insulin-induced phosphatidylinositol-3-kinase activation in peripheral blood mononuclear leucocytes from patients with Alzheimer's disease.
    Castri P; Iacovelli L; De Blasi A; Giubilei F; Moretti A; Tari Capone F; Nicoletti F; Orzi F
    Eur J Neurosci; 2007 Nov; 26(9):2469-72. PubMed ID: 17986027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rise and fall of insulin signaling in Alzheimer's disease.
    Chami B; Steel AJ; De La Monte SM; Sutherland GT
    Metab Brain Dis; 2016 Jun; 31(3):497-515. PubMed ID: 26883429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of amyloid beta-protein in Alzheimer's disease.
    Barker A
    Lancet; 1992 Oct; 340(8823):850-1. PubMed ID: 1357268
    [No Abstract]   [Full Text] [Related]  

  • 11. The influence of aging in one tauopathy: Alzheimer 's disease.
    Avila J
    Arch Immunol Ther Exp (Warsz); 2004; 52(6):410-3. PubMed ID: 15577742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual severity of AD-type lesions, Aß oligomers, and comorbidity in the brain aging.
    Bouras C; Kovari E; Savioz A; Giacobini E; Xekardaki A
    Adv Exp Med Biol; 2015; 822():17. PubMed ID: 25416972
    [No Abstract]   [Full Text] [Related]  

  • 13. Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis.
    Hoyer S
    J Neural Transm (Vienna); 1998; 105(4-5):415-22. PubMed ID: 9720971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.
    Xu W; Yang Y; Yuan G; Zhu W; Ma D; Hu S
    J Investig Med; 2015 Feb; 63(2):267-72. PubMed ID: 25479064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropathological changes in aging brain.
    Xekardaki A; Kövari E; Gold G; Papadimitropoulou A; Giacobini E; Herrmann F; Giannakopoulos P; Bouras C
    Adv Exp Med Biol; 2015; 821():11-7. PubMed ID: 25416106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's Disease.
    Verdile G; Keane KN; Cruzat VF; Medic S; Sabale M; Rowles J; Wijesekara N; Martins RN; Fraser PE; Newsholme P
    Mediators Inflamm; 2015; 2015():105828. PubMed ID: 26693205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuritic plaques in Alzheimer disease originate from neurofibrillary tangles.
    Perry G
    Med Hypotheses; 1993 Apr; 40(4):257-8. PubMed ID: 8321160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurofibrillary tangle formation and Alzheimer's disease with brain aging].
    Takashima A
    Nihon Ronen Igakkai Zasshi; 2003 Jan; 40(1):32-5. PubMed ID: 12649844
    [No Abstract]   [Full Text] [Related]  

  • 19. Commentary: is Alzheimer's disease uniquely human?
    Finch CE; Austad SN
    Neurobiol Aging; 2015 Feb; 36(2):553-5. PubMed ID: 25533426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1 beta: a common cause of Alzheimer's disease and diabetes mellitus.
    Holden RJ; Mooney PA
    Med Hypotheses; 1995 Dec; 45(6):559-71. PubMed ID: 8771051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.